-
License Agreement in Regard to a Patented Invention by the Technion-Israel Institute of Technology, exclusively held by Accellta Ltd., Has Been Entered with iPS PORTAL
License Agreement in Regard to a Patented Invention by the Technion-Israel Institute of Technology, exclusively held by Accellta Ltd., Has Been Entered with Shionogi
Israeli companies make strides in 3-D organ printing
Nano Dimension and Accellta Joined Forces to Successfully BioPrint Stem Cell-Derived Tissues
Accellta chosen as a 2016 Red Herring Top 100 Europe Winner
Cellect Announces the Signing of a Collaboration Agreement with Accellta
Ajinomoto developes StemFit cell culture medium under license from Accellta
Accellta Grants Rights for its feeder-free Stem Cell Culture Medium to Thermo Fisher Scientific
Accellta Grants Exclusive Rights for Micro-Carrier Free Stem Cells Suspension Culture to STEMCELL Technologies
Accellta featured in BioCentury Innovations Sep 2015
Exclusive Q&A interview for BioInformat - Part A - With Dr. Itzchak Angel, Accellta CEO
Exclusive Q&A interview for BioInformat - Part B - With Mr. Eran Cohen, Accellta Head of Business Development
| All rights reserved to Accellta Ltd. 2013 | PearlCom |  Web Design |